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Objective: This study was initiated to test the hypothesis that fetal hemody- 
namic changes observed under pulsatile flow bypass might be related to the 
release of endothelium-derived relaxing factor through oscillating shear stress. 
Methods: Normothermic bypass was instituted in utero in 21 preterm fetal 
lambs for a 1-hour period through the right atrium and main pulmonary 
artery. Ultrasonic flowmeters were positioned around the descending aorta 
and the umbilical artery. The circuit consisted of an oxygenator and a pump set 
to either continuous flow (n = 7) or pulsatile flow (n = 7) and adjusted to 
maintain a fetal main arterial pressure of 50 mm Hg. In seven other animals, 
endothelium-derived relaxing factor was blocked by a continuous infusion of 
N%nitro-L-arginine after 30 minutes of pulsatile flow. Results: During the first 
30 minutes of bypass, pump flows were significantly lower in the continuous- 
flow group than in the pulsatile-flow or blocked-flow groups (respectively, 
612 __ 144, 907 _+ 153 and 987 + 228 ml/min), with similar changes in aortic 
and umbilical flows. Systemic vascular resistances were significantly lower in 
the pulsatile-flow and blocked-flow groups than in the continuous-flow group 
(550 - 106 vs 821 -- 212 dynes/sec/cm-% However, after blockade of 
endothelium-derived relaxing factor, resistances increased gradually in the 
blocked-flow group to reach the level of that of the continuous-flow group at the 
end of bypass (943 - 77 vs 556 -+ 143 dynes/sec/cm -s in the pulsatile-flow 
group). Conclusions: Blockade of endothelium-derived relaxing factor after 30 
minutes of pulsatile flow returns fetal hemodynamics to continuous flow 
conditions. The specific inhibitor of endothelium-derived relaxing factor used 
in this experiment suggests that nitric oxide may be released by fetal 
endothelium during pulsatile bypass. (J Thorac Cardiovasc Surg 1997; 
114:738-45) 
E ndothelium-derived relaxing factor (EDRF)  is a labile humoral substance released from the vas- 
cular endothelium. The substance is a potent relax- 
ant of the vascular smooth muscle. 1It stimulates the 
From the Departments ofCardiovascular Surgery a and Anesthe- 
sia and Postoperative Care, b H6pital Cardiologique, and the 
National Veterinary School, c Lyon, France. 
Supported in part by a research contract (JE1949) with Claude 
Bernard University. 
Read at the Seventy-seventh Annum Meeting of The American 
Association for Thoracic Surgery, Washington, D.C., May 4-7, 
1997. 
Received for publication May 6, 1997; revisions requested June 
25, 1997; revisions received July 21, 1997; accepted for 
publication July 22, 1997. 
Address for reprints: G. Champsaur, MD, H6pital Cardi- 
ologique, 59 Boulevard Pinel, 69003, Lyon, France. 
Copyright © 1997 by Mosby-Year Book, Inc. 
0022-5223/97 $5.00 + 0 12/6/84944 
738  
soluble enzyme guanylate cyclase, which converts 
guanosine triphosphate into cyclic guanosine mono- 
phosphate. The consequent rise in the concentration 
of cyclic guanosine monophosphate l ads to vasodi- 
latation through inhibition of the contractile appa- 
ratus of the vascular smooth muscle. 2 EDRF has 
been identified as nitric oxide or a closely related 
compound and is synthesized from its precursor 
L-arginine through activation of nitric oxide syn- 
thase, found in normally functioning endothelial 
cells. The L-arginine-nitric oxide pathway is compet- 
itively inhibited by analogs such as N~°-nitro-L-argi - 
nine (N-NA). 3' 4 The release of EDRF,  eliciting 
endothelium-dependent relaxation of vascular smooth 
muscle, can be triggered by a number of pharmaco- 
logic agents, such as acetylcholine (ACH), but also by 
physical agents such as electrical-field stimulation, 
visible light, or pulsatile pressure. 5 
In the fetal lamb model, previous experiments 
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Table I. Pulse pressure values in the three groups 
before (baseline) and after 30 and 60 minutes of 
bypass 
Bypass 
T1 T2 7"3 
CF 13.28 .+ 1.37 0.14 _+ 011 0 
PF 13 _+ 2.69 10.42 -+ 2.18 10.14 _+ 1.47 
PB 13.57 .+ 2.03 10 -+ 1.46 9.57 + 1.78 
CF, Continuous flow; PF, pulsatile flow; PB, pulsatile blocked flow; T1, 
baseline, before bypass; T2, 30 minutes ofbypass; T3, 60 minutes of bypass. 
Values are expressed in millimeters ofmercury. 
have shown that irreversible hypoxia and fetal death 
resulting from placental dysfunction observed after 
regular normothermic steady-flow bypass could be 
overcome by the use of either vasoactive agents like 
prostaglandin synthesis inhibitors 6or pulsatile f low] 
This latter, when compared with continuous flow, 
was shown to enhance organ perfusion, particularly 
of  the placenta, through a diminution of vascular 
resistances. 7 
Therefore this study was undertaken to test the 
hypothesis that fetal hemodynamic hanges ob- 
served during pulsatile flow might be related to the 
release of EDRF through oscillating shear stress, 
flow changes, and rhythmic stretching of  the arterial 
wall acting as continuous stimuli on endothelial 
cells, as demonstrated in some isolated organ prep- 
arations. 5 Thus the primary end point of  the study 
was to assess the changes in fetal blood gases, blood 
flows, and vascular resistances during 1 hour of 
bypass set to continuous flow (CF group), pulsatile 
flow (PF group), or pulsatile flow blocked by an 
infusion of N -NA after a 30-minute pump run (PB 
group). No attempt was made to evaluate either 
myocardial performance or postbypass fetal sur- 
vival. 
Material and methods 
All animals included in the study received humane care 
in compliance with the "Guide of the French National 
Veterinary School" for laboratory animal studies. 
Surgical preparation. Twenty-one mixed-breed Griv- 
ette ewes between 110 and 140 days' gestation (term is 147 
days) and with a mean weight of 55 _+ 6 kg were fasted for 
24 to 48 hours before the operation. The animals were 
placed in the supine position on an operating table after 
induction of anesthesia with diazepam (0.25 rag. kg -1) 
and ketamiue (5 rag- kg -1) intravenously administered via 
the jugular vein. Ewes were endotracheally intubated and 
then connected to a volume-cycled respirator (MMS 107 
ventilator, MMS, Chelles, France) with a 10 cycles/min i respiratory rate and a 15 ml. kg- tidal volume, so as to 
keep the arterial oxygen saturation at 99% and the arterial 
Table I I . Blood gases in the three groups at the 
same time intervals as in Table I 
Bypass 
Variable flow T1 T2 T3 
pH CF 7.32 _+ 0.04 7.44 _+ 0.06 7.39 ,+ 0.07 
PF 7.30 ,+ 0.08 7.36 _+ 0.05 7.30 _+ 0.05 
PB 7.31 .+ 0.03 7.32 _+ 0.05 7.34 ,+ 0.08 
Po2 (ram Hg) CF 18.6 _+ 1.54 114.8 _+ 30.62 122.5 2 59.81 
PF 20.5 _+ 1.31 94.6 _+ 23.5 93 -+ 27 
PB 23.6 _+ 3.39 102.4 _+ 22.93 125.1 _+ 33.31 
Pco 2 (mm Hg) CF 32.2 .+ 6.05 19.1 _+ 2.77 22.6 _+ 3.77 
PF 40.9 _+ 5.88 26.4 2 8.84 24.9 .+ 8.25 
PB 41.72_+ 5.21 27.4 _+ 2.27 23:6_+ 5.85 
Po~ Oxygen tension; PCO2, carbon dioxide tension. Other abbreviations as 
in Table I. 
carbon dioxide tension within normal limits. Anesthesia 
was maintained with inhalation of  a mixture of 1% to 
1.5% halothane supplied by a Fluotec vaporizer (Ohmeda 
[West Yorkshire], Yorkshire, United Kingdom) and 50% 
nitrous oxide. Expired gases (oxygen, carbon dioxide, and 
halothane) were continuously analyzed with a Hewlett- 
Packard HP M1015B analyzer (Hewlett-PaCkard, Bron, 
France) to adjust volume and percentage of inspired gases 
for an optimal ventilation. A large-bore intravenous cath- 
eter was inserted into the left jugular vein for fluid 
infusion to maintain adequate uterine perfusion and avoid 
fetal and maternal hypoglycemia. An arterial line was 
introduced in the femoral artery through a cutdown for 
maternal heart rate and blood pressure monitoring, as 
well as blood gas sampling. 
Fetal surgery was carried out according to a previously 
described technique. 7 Essentially, after exposure of the 
uterus through a low midline laparotomy and a small 
hysterotomy, ketamine (50 mg) was administered intra- 
muscularly into a fetal hind limb. Through a fetal neck 
incision, Catheters were inserted into the jugular vein and 
the common carotid artery for fetal perfusion, blood 
pressure monitoring, and blood gas sampling. The umbil- 
ical cord was gently mobilized, and a 4S to 6S ultrasonic 
flo w probe was placed around the umbilical artery (Tran- 
sonic Systems, Inc., Ithaca, N.Y.) for placental or umbil- 
ical blood flow monitoring, special care being taken to 
avoid any kinking or tension on the cord. After gentle 
exteriorization avoiding amniotic fluid losses, the fetus 
was placed on an isolating pad and the temperature was 
constantly monitored by a rectal probe. A fetal midline 
sternotomy was then performed, and the pericardium was 
opened and suspended. Right and left pulmonary arteries 
were dissected out and encircled with tapes. An ultrasonic 
flowmeter (8S to 10S, Transonic) Was positioned around 
the descending aorta, right after the ductus arteriosus. 
Purse-string sutures of 5-0 Ti-Cron polyester (Davis & 
Geck, Bondoufle, France) were placed on the proximal 
main pulmonary artery and on the right atrial wall. A 300 
U/kg dose of heparin was administered intravenously to 
the fetus. A 12F arterial cannula (Bard SA, Trappes, 
France) was inserted into the proximal main pulmonary 
artery and a 14F venous canula (Dideco SA, Antony, 
France) was introduced into the right atrium. After con- 
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Fig. 1. Systemic vascular esistances in each group: CF, Continuous flow; PF, pulsatile flow; PB, pulsatile 
blocked flow. The values are depicted in each group every 10 minutes during the bypass time. N-NA 
(N°'-nitro-L-arginine) infusion was started at the thirtieth minute of bypass, *Between-group differences at 
the sixtieth minute of bypass. °Within-group differences before and after N-NA infusion. 
Table I I I .  Values of pump and aortic and placental 
blood flows in each group before (7"1) and at 30 
(T2) and 60 (T3) minutes of bypass 
Variable Group T1 T2 T3 
Pump flow CF 612 +_ 144' 530 +_ 54 
PF 907 _+ 153 941 _+ 228* 
PB 987 -+ 228* 607 _+ 117 
Aortic flow CF 430.71 _+ 82.17 224 _+ 132" 198 _+ 72 
PF 478.71_+ 71.1 458_+ 213 405_+ 177" 
PB 438.14 _+ 54.42 421 _+ 123 187 _+ 88 
Umbilical flow CF 266.14 +47.55 61 _+ 24* 66 _+ 23 
PF 232.42 +_ 47.63 181 _+ 71 208 + 90* 
PB 308.57 -+ 41.11 132 _+ 70 50 _+ 22 
Pump flow in aortic and umbilical flows in are given in milliliters per 
minute per kilogram. 
*p < 0.05 between groups (analysis of variance) at a given time T1, T2, or 
T3. 
nection to the circuit, both right and left pulmonary 
arteries were occluded by the previously placed tapes to 
prevent pulmonary arterial overflow, and normothermic 
bypass was instituted for 60 minutes. After cessation of 
bypass, the fetus was killed, weighed, and a complete 
autopsy was performed. Positions of the catheters were 
checked and all available urine was collected from the 
bladder by direct puncture, urinary samples being imme- 
diately Stored at -20 ° C. The placenta was removed from 
the uterus along with the twin fetus, if any. The hysterot- 
omy and laparotomy were closed in layers. The ewe was 
then allowed to recover under sedation and antibiotic 
prophylaxis. 
Experimental protocol. The bypass circuit consisted of 
a bubble oxygenator (Optiflow II, Cobe Laboratories, 
Inc., Lakewood, Colo,) incorporating a heat exchanger 
and primed with 700 ml of freshly drawn heparinized adult 
sheep donor blood diluted with 300 ml of Ringer's lactate 
solution. The gas flow through the oxygenator was a 
mixture of 10% oxygen/90% nitrogen and was adjusted to 
maintainfetal oxygen and carbon dioxide tensions within 
normal limits. Bypass was conducted with a centrifugal 
pump (Deiphin II centrifugal system, Sarns/3M Health 
Care, Ann Arbor, Mich.) consisting of a 48 ml volume 
pump head and delivering either a continuous (CF group) 
or an asynchronous pulsatile flow (PF group) at 60 
cycles/min. After the onset of bypass the fetal heart was 
routinely fibrillated to rule out any contribution to the 
bypass flow and pulsatility. Pump floWs were constantly 
monitored by an ultrasonic 6C flow sensor (Transonic) 
placed around the 1/4-inch arterial line and were adjusted 
to deliver a fetal mean blood pressure within the physio- 
logic range of 45 to 50 mm Hg. The animals (n -- 21) were 
randomly assigned to one of three groups, according to 
the type of fetal bypass: continuous flow (CF, n = 7), 
pulsatile flow (PF, n = 7), or blocked puisatile flow (PB, 
n = 7): In the PB group, so that we could test a potential 
modification of the vascular endothelium release of vaSo- 
active substances under pulsatile flow conditions, fetuses 
were perfused with N-NA, a stereospecific EDRF inhibi- 
tor (Sigma Chemical Co., St. Quentin Fa!avier, France). 
The animals in the PB group received a bolus injection of 
the diluted N-NA solution (20 mg. kg -1) slowly injected in 
the fetal jugular vein at the thirtieth minute of bypass, 
followed by a 20 rag. kg -1 • hr -~ continuous infusion for 
the next 30 minutes up to the end of bypass. In previous 
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Fig. 2. Placental vascular esistances as calculated before (baseline) and 30 and 60 minutes after the 
initiation of bypass in each group. Abbreviations as in Fig. 1. 
studies, this dose had been shown to block EDRF pro- 
duction, s So that the effectiveness of subsequent EDRF 
blockade caused by N-NA could be determined, the 
baseline hemodynamic response to an endothelium-de- 
pendent vasodilator was evaluated by injection of ACH, 
45 /zg (Sigma Chemical), into the fetal jugular vein 
performed at the fortieth minute of bypass. Immediately 
before each experiment, N-NA, 450 rag, was extempora- 
neously dissolved in a solution of 45 ml of 0.9% sodium 
chloride. ACH 10 mg was diluted in 1 L of sodium 
chloride, 1 ml representing 10/zg. 
Data acquisition. Fetal and maternal hemodynamic 
parameters were measured and continuously monitored 
with Baxter transducers (Uniflow pressure set, Baxter 
Healthcare Corp., Bentley Laboratories Europe) and 
multichannel recorders (Kone Corporation Instruments 
Division, Espoo, Finland). All flows were measured on 
Transonic T206 flowmeters: Blood gases sampled from 
maternal femoral and fetal carotid arteries were immedi- 
ately analyzed (arterial oxygen and carbon dioxide ten- 
sions and pH) on a Radiometer ABL 330 gas analyzer 
(Radiometer A/S, Copenhagen, Denmark). Hemoglobin 
concentration was measured on a hemoglobin photometer 
(HemoCue, ~mgelholm, Sweden). 
Data were collected after anesthesia induction, 10 
minutes before the onset of bypass, and every 10 minutes 
thereafter until 10 minutes after the termination of the 
60-minute bypass. Fetal urinary excretion of nitric oxide 
metabolites (nitrites and nitrates) was measured in the 
three groups at the end of the procedure, the concentra- 
tion being measured after dilution in distilled water, and 
incubation with nitrate reductase and flavine adenosine. 9 
Data analysis. Before the onset of bypass, total cardiac 
output was not measured because fetal anatomy made 
placement of a flow probe around the distal aorta, above 
the ductus, almost impossible without compromising the 
hemodynamic stability of the animal. Once bypass was 
begun, flow delivered by the pump in the setting of this 
preparation with a fibrillating heart and excluded pu!mo- 
nary circulation could be considered as the cardiac output. 
Systemic and placental vascular resistances were calcu- 
lated with the use of standard formulas. Data were stored 
on a spreadsheet database and were analyzed with CSS 
Statistica statistical package (Statsofl Inc., Tulsa, Okla.). 
Values were expressed as mean + standard error of the 
mean. Between-group differences were compared with 
one-way analysis of variance and repeated-measures two- 
way analysi  of variance. Within-group differences were 
analyzed with t tests for dependent samples. Nonparamet- 
ric tests were used when appropriate. Statistical signifi- 
cance was established at the 5% level. 
Results 
Hemoglobin values did not differ in any group 
before bypass (mean 11.2 _+ 4.1 gm/dl) or after 60 
minutes, at which time a nonsignificant drop was 
similar in each group (mean 8.1 _+ 4.1 gm/dl). In the 
CF group, the pulse pressure disappeared at initia- 
tion of bypass because the heart was fibrillating in 
every group. In both the PF and PB groups, the 
pulse pressure was not significantly different once 
bypass was begun (Table I). However, the heart rate 
was slower, fixed at 60 cycles/rain, according to the 
built-in specifications of the device. 
Oximetry. Blood gas data were similar between 
groups from baseline values until the onset of 
bypass. Once bypass was begun, there was a trend 
toward a relative hyperoxia lthough the oxygenator 
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Fig. 3. Changes in the mean arterial blood pressure of fetuses in each group following abolus injection of 
acetylcholine (ACH). Abbreviations a in Fig. 1. 
was flushed most times with room air, and there 
were no significant between-group differences atany 
time during the bypass, whatever the type of flow 
(Table II). 
ttemodynamies. No significant differences in ei- 
ther aortic or umbilical flows were noted among the 
three groups before bypass (Table III). After 30 
minutes of bypass (T2), pump flow in the CF group 
was significantly ower than in either the PF or PB 
groups, which by definition did not differ (Table III). 
The same trend was followed by aortic flow and 
umbilical flow, which were significantly ower in the 
CF group. At 60 minutes of bypass, all flows were 
significantly ower in the CF than in the PF group. 
At this point in the PB group, however, where 
animals had been submitted to pulsatile flow for 30 
minutes with subsequent EDRF blockade by N-NA, 
all flows decreased tovalues not different from those 
of the CF group, but significantly different from 
those of the PF group. Flows within the PB group 
also differed significantly at 30 and 60 minutes of 
bypass (Table III). Systemic Vascular resistances 
were significantly ower in groups PF and PB than in 
group CF (perfused with continuous flow) (Table 
III). After EDRF blockade performed in group PB 
at 30 minutes of bypass, systemic vascular esis- 
tances increased gradually to reach the level of those 
of group CF at the termination of bypass (Fig. 1). 
Placental vascular resistances followed a similar 
evolution between and within groups, being not 
different between CF and PB groups at the end of 
the 60-minute bypass, whereas placental vascular 
resistances in the PB group were not different from 
those of the PF group until EDRF blockade (Fig. 2). 
ACH bolus injection at the fortieth minute of bypass 
(after a 10-minute duration of EDRF blockade) was 
followed by an immediate and transient drop in 
blood pressure in both the CF and PF groups, 
whereas the blood pressure in the PB group re- 
mained unchanged (Fig. 3). Finally, the level of 
urinary nitrates was lower, although not significantly 
so, in the CF group (450.57 -- 110.36/xmol/L) than 
in either the PF group (546.28 _+ 53.76 ~mol/L) or 
the PB group (570.85 _ 85.51 ~mol/L). 
Discussion 
In the era of early prenatal echographic diagnosis 
of most congenital defects, along with clinical fetal 
surgery performed for noncardiac defects, 1° the 
search for an optimal technique of fetal bypass till 
goes on. In this direction, we have investigated the 
potential benefits of adding a pulsatile flow to fetal 
perfusion. We had shown in a preliminary work 7 
that pulsatility improves hemodynamics during fetal 
bypass through a significant decrease of systemic 
and placental vascular resistances. The present 
study was then undertaken after the observation 
that modifications in flows, and particularly pulsatile 
flows, are known triggers of EDRF release on 
isolated arterial segments. 3' s
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When applied to clinical cardiac surgery, pulsatile 
flow remains a highly controversial subject, 11 partly 
because most pulsatile devices used in this setting 
are unable to deliver a proper pulsatile flow. 12 
Regarding our own preparation, one of the main 
criticisms is related to the specifications of the 
pump, which on the pulsatile mode has a fixed rate 
of 60 beats/min, much slower than the physiologic 
preterm fetal heart rate. 8However, the pulse pres- 
sure during bypass was not significantly different 
from the prebypass one. 
Other investigators have extensively explored 
other ways of improving the tolerance of fetal 
bypass, including the addition of vasodilators, 6' 13 
steroids, I4the prevention of fetal stress, Is or the use 
of less invasive perfusion techniques, 16 but always 
on a shorter bypass run (30 minutes). We have 
concentrated instead on triggering the release of 
endothelial utacoids by mechanical means uch as 
flow changes with a 60-minute bypass time. The use 
of an oxygenator then becomes mandatory tomain- 
tain fetal blood gases at a constant level, thus ruling 
out hemodynamic biases, and to keep the animal 
temperature constant over time. In the current 
study, normothermia was part of the fetal stress 
management, along with fetal anesthesia and deli- 
cate manipulation avoiding amniotic fluid losses. 
Conversely, the oxygenator b ings up other related 
issues like exposure to increased blood-contacting 
surfaces and priming volume with adult sheep 
blood. These are widely known factors of placental 
dysfunction 16 and of endothelial dysfunction that we 
were not willing to eliminate because they are part 
of clinical cardiopulmonary b pass. 
The current study confirms the benefits of pulsa- 
tile flow in this specific preparation for up to 1 hour 
of bypass to maintain systemic and placental vascu- 
lar resistances at an acceptable l vel that is also 
significantly ower than that observed uring contin- 
uous flow. EDRF blockade as it is achieved through 
N-NA infusion seems then to simulate the endothe- 
lial dysfunction resulting from the continuous flow 
perfusion, with a return to similar flow values after 
30 minutes of EDRF release inhibition. The endo- 
thelium-dependent ACH action is also confirmed, 
the animals in the PB group remaining insensitive to 
the drug. In the CF group, however, the ACH- 
induced pressure drop was constantly observed, 
although the pressure change was not significant as 
compared with the one observed in the PB group. 
This may suggest hat the endothelial dysfunction 
observed during continuous flow was less severe 
than that generated by EDRF blockade. ACH- 
induced vasodilation observed uring fetal bypass 
suggests that nitric oxide synthase ispresent in fetal 
endothelium, as pointed out by other investiga- 
tors.17, 18 
It remains unclear why the urinary nitrate levels 
did not differ significantly between the pulsatile (PF 
and PB) and nonpulsatile (CF) groups. First, fetal 
diuresis was difficult to quantify, the bladder not 
being empty at the beginning of the experiment and 
the whole volume of urine being collected at the end 
of the procedure. Second, in the absence of sequen- 
tial urinary sample collection during the bypass 
period, it was impossible to discriminate in the PB 
group which concentration was due to either pulsa- 
tile flow or blocked pulsatile flow. 
Thus pulsatile perfusion may act as a donor of 
EDRF. The explanation for EDRF release during 
pulsatile flow usually invoked in experiments on 
isolated arterial segments i that of rhythmic stimu- 
lation of endothelial cells through oscillating 
changes in vessel wall shear stress. 2' 3, s This may 
stimulate a renewed interest in pulsatile perfusion 
for patients with impaired endothelial function, 
particularly in three clinical situations. One is the 
elderly patient in whom the aging or regenerated 
endothelium 3 may benefit from an EDRF donor 
during perfusion. The same suggestion is potentially 
applicable to atherosclerosis-damaged rterial wall. 
The third situation is that of jeopardized myocar- 
dium with severe impairment of endothelial func- 
tion for the reversal of which, among other adjuncts, 
L-arginine supplementation has been advocated. 19 
Pulsatile flow reperfusion would theoretically bring 
the same advantages in this situation. 
In summary, when pulsatile flow during fetal 
bypass is subjected to a competitive EDRF inhibi- 
tor, systemic and placental vascular esistances re- 
turn to values not different from those observed in 
the same conditions during continuous flow. This 
suggests that pulsatile bypass may stimulate nitric 
oxide release from endothelial cells. 
We acknowledge the expert technical assistance of 
M. T. Poirel, ENV, Lyon, France. 
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Discussion 
Dr. Robert C. Robbins (Stanford, Calif.). I have just a 
few questions. You mentioned the stress response. What 
anesthetic agents did you use? 
Second, we have also used an oxygenator system and a 
total extracorporeal system for fetal bypass in lambs. Did 
you use hyperoxygenation r did you use low levels of 
oxygenation? We have been concerned that using high 
levels of oxygenation might affect the ductus. 
Finally, you mentioned that you obtained blood gases. I
would like to know what happens after bypass in these 
animals? In our experience the flows and blood gases are 
fine during bypass, but then within an hour or two after, 
the animal becomes acidotic, especially when we use 
hyperoxygenation. 
Dr. Champsaur. Thank you for your nice remarks. We 
used ketamine in the fetuses, intramuscularly, as an 
anesthetic agent, and we did try to keep the level of 
oxygenation as close as possible to the physiologic level. 
Nevertheless, after the end of 1 hour of bypass, there was 
some trend toward hyperoxia. 
Finally, to address the question regarding blood gases, 
the study was not aimed at fetal survival, so we were not 
interested in the late outcome of the fetus after bypass. 
The animals were routinely killed at the end of the 
procedure. 
Mr. Magdi Yaeoub (London, United Kingdom). I have 
three very quick questions. Why did you select a fetal 
model? Do you think there is difference between fetal and 
adult models? 
Second, have you quantified the amount of pulsatility? 
Do you think that matters, whether there is a minimum 
amount of pulsatility required or there is a dose-response 
relationship? 
Finally, what do you think is the relationship between 
the capacity of the endothelium to respond to pharmaco- 
logic or mechanical stimuli? Are these two completely 
separate things, or are they linked? 
Dr. Champsaur: Thank you, Mr. Yacoub, for your 
remarks. Why the fetal model? The reason is that we have 
used that model for a couple of years now and we are 
more familiar with it than with any other model. We also 
think that this is a very highly sensitive model for the study 
of the circulation as compared with adult animals. 
Regarding the amount of pulsatility, the pulse pressure 
remained fairly stable during the whole procedure in the 
PF group, with a pulse pressure of about 30 to 35 mm Hg. 
The hearts were routinely fibrillated to rule out any 
contribution of the native heart to either flow or pulsatil- 
ity. 
Dr. John H. Kennedy (Cambridge, United Kingdom). I
have only one simple question. In your abstract you refer 
to measurements of shear stress. How was shear stress 
measured? 
Dr. Champsanr. There was no direct measurement of 
the shear stress in this study, and I don't think there was 
any reference to shear stress measurement in the 
abstract. We hypothesized that pulsatile flow would act 
through a shear stress modification during pulsatile 
flow, but there was no direct measurement of that 
particular variable. 
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Dr. James Frederiksen (Chicago, Ill.). You said that you 
kept the arterial pressure at 50 mm Hg. Can you increase 
the continuous flow to 900 ml/min if you increase the 
mean arterial pressure? 
Dr. Champsaur. Yes, we certainly could do so. The 
main end point was to keep the blood pressure level 
within physiologic limits, which in this particular case is 
around 50 mm Hg. By increasing the flows in the contin- 
uous-flow preparation, we were able to increase also the 
blood pressure very rapidly, but to a really high hyperten- 
sive level that was unsafe to keep anyway. Again, this was 
not the aim of the study. 
Dr. Edward D. Verrier (Seattle, Wash.). My final ques- 
tion has to do with the relative importance ofthe prostaglan- 
din system versus nitric oxide. Work that Frank Hanley and 
we have done previously at the University of California at 
San Francisco showed that the placenta isan extraordinarily 
rich circulation with prostaglandins. Indomethacin blocks all 
of these responses. Can you put into context what you think 
is the relative importance ofprostaglandin to EDRF in terms 
of regulation of the fetal circulation or the placental circu- 
lation based on this work? 
Dr. Champsaur. Dr. Verrier, we are very well aware of 
your previous work on the fetal bypass and circulation. 
What I know is that prostaglandin inhibitors, as they have 
been used by Frank Hanley and your group in the past, are 
endothelium-independent factors, whereas the pulsatile 
flow indirectly might be an endothelium-dependent factor 
through EDRF release and that may be the main differ- 
ence between the two studies. 
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